Skip to main content

Asherman's Syndrome clinical trials at UCSF
1 in progress, 1 open to new patients

  • Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair

    open to eligible females ages 18 years to 43 years

    Patients with intrauterine adhesions (Asherman's Syndrome) and persistent thin endometrial lining in in vitro fertilization (IVF) treatment programs, particularly those resistant to standard therapies, present a significant clinical challenge. The aim of this trial is to assess if intrauterine administration of platelet rich plasma (PRP) improves endometrial lining thickness in patients with thin lining or Asherman's Syndrome.

    San Francisco, California